These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12854942)

  • 21. The use of selective serotonin antagonists in the palliation of intractable nausea: implications for the clinical nurse specialist.
    Doorley J; Hobbs M
    Clin Nurse Spec; 2004; 18(6):282-4. PubMed ID: 15602266
    [No Abstract]   [Full Text] [Related]  

  • 22. Report of three case studies with olanzapine for chronic pain.
    Gorski ED; Willis KC
    J Pain; 2003 Apr; 4(3):166-8. PubMed ID: 14622714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine in the Treatment of Refractory Nausea and Vomiting in Palliative Care Settings.
    Gupta N; Puri S; Kumar V; Garg R; Bharati SJ; Mishra S; Bhatnagar S
    Indian J Palliat Care; 2018; 24(3):372-374. PubMed ID: 30111956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Zyprexa (olanzapine)--new possibilities in the treatment of schizophrenia].
    Litvintsev SV; Reznik AM; Arbuzov AL; Kutushev OT; Shcherbakov DV
    Voen Med Zh; 2002 Sep; 323(9):46-50. PubMed ID: 12449756
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of cervical dystonia by olanzapine.
    Kuniyoshi M; Ohyama S; Otsuka M; Nishi S; Inanaga K; Mori N
    Hum Psychopharmacol; 2003 Jun; 18(4):311-2. PubMed ID: 12766936
    [No Abstract]   [Full Text] [Related]  

  • 26. Opioid induced nausea and vomiting.
    Smith HS; Laufer A
    Eur J Pharmacol; 2014 Jan; 722():67-78. PubMed ID: 24157979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
    Domon SE; Webber JC
    J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing for nausea in palliative care: a cross-sectional national survey of Australian palliative medicine doctors.
    To TH; Agar M; Yates P; Currow DC
    J Palliat Med; 2014 Sep; 17(9):1032-6. PubMed ID: 25153165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose levomepromazine (methotrimeprazine) to control nausea in carcinoid syndrome.
    Amesbury B; Alloway L; Hickmore E; Dewhurst G
    J Palliat Care; 2004; 20(2):117-8. PubMed ID: 15332477
    [No Abstract]   [Full Text] [Related]  

  • 30. Olanzapine induced delirium-a "probable" adverse drug reaction.
    MacKintosh D
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S257-S259. PubMed ID: 28866898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
    Yamasaki F; Watanabe Y; Nosaka R; Kenjo M; Nakamura K; Takayasu T; Saito T; Tominaga A; Sugiyama K; Kurisu K
    No Shinkei Geka; 2014 Jan; 42(1):27-34. PubMed ID: 24388937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eruptive xanthomas associated with olanzapine use.
    Chang HY; Ridky TW; Kimball AB; Hughes E; Oro AE
    Arch Dermatol; 2003 Aug; 139(8):1045-8. PubMed ID: 12925394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine efficacy in the treatment of essential tremor.
    Yetimalar Y; Irtman G; Gürgör N; Başoğlu M
    Eur J Neurol; 2003 Jan; 10(1):79-82. PubMed ID: 12534999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resurgence of Eating Disorders with Olanzapine.
    Wu KL; Lorenz AK; Christensen KJ; Feely MA; Carey EC; Strand JJ
    J Palliat Med; 2019 Feb; 22(2):231-233. PubMed ID: 30376403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Pearls in palliative medicine.
    Feely MA; Litin SC; Bundrick JB
    Dis Mon; 2017 Jun; 63(6):134-140. PubMed ID: 28651689
    [No Abstract]   [Full Text] [Related]  

  • 38. Approval by MREC of a modified patient information and consent form. does this set a precedent for trials in palliative care?
    Dentith JR; Hardy JR
    Palliat Med; 2004 Jul; 18(5):484-5. PubMed ID: 15332428
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of orally disintegrating olanzapine tablet for patients with cancerous peritonitis and postoperative gastric cancer receiving home palliative care].
    Murakami N; Tanabe K; Yamatani K; Kitazawa H; Fujikawa Y; Amemiya Y; Shimada M; Kadoya S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):649-52. PubMed ID: 22504695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Erard E; Blondel N
    Rev Med Suisse; 2020 Sep; 16(705):1664. PubMed ID: 32914602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.